A new trading day began on Monday, with ProKidney Corp (NASDAQ: PROK) stock price down -13.04% from the previous day of trading, before settling in for the closing price of $2.53. PROK’s price has ranged from $0.46 to $7.13 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 8.60%. With a float of $105.52 million, this company’s outstanding shares have now reached $135.98 million.
ProKidney Corp (PROK) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of ProKidney Corp is 25.45%, while institutional ownership is 28.52%. The most recent insider transaction that took place on Nov 13 ’25, was worth 1,190,062. In this transaction Director of this company sold 502,136 shares at a rate of $2.37, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Director sold 255,026 for $2.72, making the entire transaction worth $694,515. This insider now owns 54,333 shares in total.
ProKidney Corp (PROK) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.17 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.60% per share during the next fiscal year.
ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators
Here are ProKidney Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 894.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.54, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.60 in one year’s time.
Technical Analysis of ProKidney Corp (PROK)
Looking closely at ProKidney Corp (NASDAQ: PROK), its last 5-days average volume was 0.84 million, which is a drop from its year-to-date volume of 4.29 million. As of the previous 9 days, the stock’s Stochastic %D was 68.44%.
During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 11.11%, which indicates a significant decrease from 26.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.17 in the past 14 days, which was lower than the 0.22 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.56, while its 200-day Moving Average is $1.97. However, in the short run, ProKidney Corp’s stock first resistance to watch stands at $2.43. Second resistance stands at $2.67. The third major resistance level sits at $2.79. If the price goes on to break the first support level at $2.08, it is likely to go to the next support level at $1.96. Now, if the price goes above the second support level, the third support stands at $1.72.
ProKidney Corp (NASDAQ: PROK) Key Stats
With a market capitalization of 661.83 million, the company has a total of 300,834K Shares Outstanding. Currently, annual sales are 80 K while annual income is -61,190 K. The company’s previous quarter sales were 220 K while its latest quarter income was -16,470 K.
